Ensysce Biosciences, Inc. (ENSC) vs NeuroSense Therapeutics Ltd. (NRSN)
A side-by-side comparison of Ensysce Biosciences, Inc. and NeuroSense Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENSC
Ensysce Biosciences, Inc.
$0.43HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
NRSN
NeuroSense Therapeutics Ltd.
$4.01HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
Total return — ENSC vs NRSN
growth of $100 · dividends reinvested · last 5yENSC -100.0% (-86.9%/yr)NRSN -95.0% (-45.1%/yr)NRSN compounded faster over this window
Log scale — wide-divergence pair
ENSC NRSN
ENSC vs NRSN: by the numbers
- •NRSN is the larger company ($7M vs $7M market cap).
- •Both run net losses; NRSN's is the smaller (0.00% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | ENSC | NRSN |
|---|---|---|
| P/S ratio | 5.67 | N/A |
Profitability
| Metric | ENSC | NRSN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -1084.23% | 0.00% |
Growth (annualized)
| Metric | ENSC | NRSN |
|---|---|---|
| Total return CAGR (5Y) | -86.22% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.